Clinical Trial Update: SKG0201 Gene Therapy for Spinal Muscular Atrophy Type 1 (SMA 1)
Trial ID: NCT06191354Study Title: A Multicenter, Open, Dose-Escalation Clinical Study Evaluating the Safety, Init...
spinal-muscular-atrophy-treatment
GC101 Gene Therapy for Spinal Muscular Atrophy Type 2 – Phase I/II Clinical Trial
ClinicalTrials.gov Identifier: NCT05901987Sponsor: GeneCradle Inc.Study Title: Safety and Efficacy of GC101 Gene The...
spinal-muscular-atrophy-treatment
Phase III Trial: GC101 Gene Therapy for Type 2 Spinal Muscular Atrophy (SMA)
ClinicalTrials.gov Identifier: NCT06971094Sponsor: GeneCradle Inc.Study Title: Safety and Efficacy Evaluation of GC101 Gen...
spinal-muscular-atrophy-treatment